What’s New

News & Announcements

Poster Presentations at the AACR 2024 Annual Meeting for OBI-992 and GlycOBI™ ADC platform

Adagloxad Simolenin (OBI-822)/OBI-821, receives a positive 1st interim analysis recommendation, suggesting the continuation of the Phase III TNBC trial

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992


2024 Annual Shareholders’ Meeting

  • 2024.Jun.17 at 09:00 AM
  • Masterlink Securities Education and Training Center
  • Event Time2024.Jun.17
  • Event LocationMasterlink Securities Education and Training Center
  • Published Date2024.May.14
Company PresentationShareholder Meeting HandbookShareholder Meeting Notice

2024 ASCO Annual Meeting

  • 2024.May.31 ~ 2024.Jun.04
  • McCormick Place, Chicago, IL, USA
  • Event Time2024.May.31 ~ 2024.Jun.04
  • Event LocationMcCormick Place, Chicago, IL, USA
  • Published Date2024.May.28

2024 AACR Annual Meeting

  • 2024.Apr.05 ~ 2024.Apr.10
  • San Diego Convention Center (San Diego, California)
  • Event Time2024.Apr.05 ~ 2024.Apr.10
  • Event LocationSan Diego Convention Center (San Diego, California)
  • Published Date2024.May.28

2023 Investor Meeting

  • 2023.Dec.06 at 02:30 PM
  • Taipei Bioinnovation Park 1F Conference Room